Aniridia Clinical Trial
Official title:
Clinical Outcomes of Implantationof Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture
| NCT number | NCT03581864 |
| Other study ID # | 0002 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | January 1, 2006 |
| Est. completion date | May 1, 2018 |
| Verified date | June 2018 |
| Source | Medical University of Lublin |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Purpose: To assess long-term outcomes of implantation of black diaphragmintraocular lens (BD
IOL) in postraumatic aniridia and aphakia due to eye rupture.
METHODS: This is retrospective consecutive case series of 14 eyes with post-traumatic
complete aniridia and aphakia treated withscleral fixation of BD IOL with. Measurements
included ophthalmological comorbidities, best corrected visual acuity (BCVA), complications,
and postoperative interventions. The average postoperative follow-up period was 36 months.
| Status | Completed |
| Enrollment | 14 |
| Est. completion date | May 1, 2018 |
| Est. primary completion date | December 31, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 25 Years to 79 Years |
| Eligibility |
Inclusion Criteria: post-traumatic complete aniridia and aphakia Exclusion Criteria: active ocluar inflammation or infection |
| Country | Name | City | State |
|---|---|---|---|
| Poland | General Department of Ophthalmology in Lublin | Lublin |
| Lead Sponsor | Collaborator |
|---|---|
| Medical University of Lublin |
Poland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Best-corrected visual acuity | The visual acuity measurement with ETDRS chart | 10 to 120 months | |
| Primary | The slit lamp examination | The anterior segment of the eye and eye fundus were examined. | 10 to 120 months | |
| Primary | The intrraocular pressure measurement | The procedure was performed with the Goldman applanation tonometer. | 10 to 120 months | |
| Primary | The medical history | Coexisting eye diseases and post-operative complications were noted. | 10 to 120 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00758108 -
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
|
||
| Not yet recruiting |
NCT06412718 -
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
|
||
| Recruiting |
NCT05400590 -
Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients
|
||
| Recruiting |
NCT05044598 -
RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
| Completed |
NCT00001161 -
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
|
N/A | |
| Enrolling by invitation |
NCT03461978 -
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
|
N/A | |
| Recruiting |
NCT05954403 -
National Cohort on Congenital Defects of the Eye
|
||
| Completed |
NCT02647359 -
Study of Ataluren in Participants With Nonsense Mutation Aniridia
|
Phase 2 | |
| Recruiting |
NCT05562115 -
Proteomic Study of Tears From Patients With a PAX6 Mutation
|
N/A | |
| Completed |
NCT00265590 -
Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia
|
N/A | |
| Withdrawn |
NCT04117880 -
A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia
|
Phase 2 | |
| Active, not recruiting |
NCT00503893 -
Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
|
||
| Completed |
NCT01644552 -
Positive Angle Kappa
|
||
| Completed |
NCT00812708 -
Clinical Evaluation of Morcher Artificial Iris Diaphragms
|
N/A |